Today’s Solutions: June 12, 2026

The inability to detect Alzheimer’s early is one main reason pharmaceutical companies have not been able to develop a drug to combat the disease, which is the most common form of dementia. That’s why it’s great news that researchers have just developed a simple blood test that shows evidence of brain damage due to Alzheimer’s almost seven years before any kind of cognitive change occurs. Theoretically, this test could be used to find patients who will go on to develop the disease, so that in the near future they could be enrolled in drug trials, and in the long term, could be saved from developing dementia.

Solutions News Source Print this article
More of Today's Solutions

Dinner scraps are rebuilding California’s lost oyster reefs

BY THE OPTIMIST DAILY EDITORIAL TEAM What if scraps from a dinner could become a habitat? That's the basic premise of the Shells for ...

Read More

5 habits that separate growing teams from stagnant ones

BY THE OPTIMIST DAILY EDITORIAL TEAM The strategy is fine. The team is capable. But at the end of the quarter, the needle hasn’t ...

Read More

How a rickshaw driver’s son beat the odds to join a famed UK ballet school

Kamal Singh was 17-years-old when he first became transfixed by ballet dancers in a Bollywood film. At that moment, the son of a rickshaw ...

Read More

Food sequencing: how eating in the right order can boost your health

BY THE OPTIMIST DAILY EDITORIAL TEAM When we think about balanced eating, most of us focus on what’s on our plate—fiber, protein, vitamins, and ...

Read More